AJANTA PHARMA LTD.
Market Cap.(`)
|
30194.81 Cr.
|
P/BV
|
8.46
|
Book Value (`)
|
283.30
|
52 Week High/Low ( ` )
|
2540/1247
|
FV/ML
|
2/1
|
P/E(X)
|
37.00
|
Book Closure
|
08/02/2024
|
EPS (`)
|
64.82
|
Div Yield (%)
|
2.13
|
(` in Crs.)
You can view the
Consolidated
Income Statement
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 4208.71 | 3707.52 | 3284.13 | 2845.20 | 2558.52 |
Other Operating Revenues | 0.00 | 35.12 | 56.86 | 44.49 | 29.35 |
Total Operating Revenues | 4208.71 | 3742.64 | 3340.99 | 2889.69 | 2587.87 |
| | | | | |
Other Income | 84.60 | 98.64 | 115.68 | 25.98 | 92.19 |
Total Revenue | 4293.31 | 3841.28 | 3456.67 | 2915.67 | 2680.06 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 939.43 | 878.36 | 779.34 | 706.41 | 560.33 |
Purchase Of Stock-In Trade | 166.35 | 146.28 | 136.10 | 89.54 | 112.13 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -39.21 | 25.76 | -83.17 | -150.90 | -16.75 |
Employee Benefit Expenses | 900.34 | 785.14 | 645.78 | 548.25 | 485.59 |
Finance Costs | 7.21 | 5.84 | 10.20 | 8.27 | 11.91 |
Depreciation And Amortisation Expenses | 135.40 | 130.80 | 125.30 | 116.09 | 95.72 |
Other Expenses | 1069.86 | 1123.85 | 933.64 | 697.83 | 763.24 |
Total Expenses | 3179.38 | 3096.03 | 2547.19 | 2015.49 | 2012.17 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1113.93 | 745.25 | 909.48 | 900.18 | 667.89 |
| | | | | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -3.92 |
Profit/Loss Before Tax | 1113.93 | 745.25 | 909.48 | 900.18 | 663.97 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 297.76 | 175.58 | 217.22 | 269.74 | 186.35 |
Deferred Tax | 0.00 | -39.97 | 4.94 | -15.05 | 9.92 |
Tax For Earlier Years | 0.00 | 21.66 | -25.36 | -8.38 | 0.00 |
Total Tax Expenses | 297.76 | 157.27 | 196.80 | 246.31 | 196.27 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 816.17 | 587.98 | 712.68 | 653.87 | 467.70 |
| | | | | |
Profit/Loss From Continuing Operations | 816.17 | 587.98 | 712.68 | 653.87 | 467.70 |
| | | | | |
Profit/Loss For The Period | 816.17 | 587.98 | 712.68 | 653.87 | 467.70 |
Consolidated Profit/Loss After MI And Associates | 816.17 | 587.98 | 712.68 | 653.87 | 467.70 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 64.82 | 45.89 | 82.45 | 75.09 | 53.60 |
Diluted EPS (Rs.) | 64.77 | 45.89 | 82.45 | 75.09 | 53.60 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 89.69 | 82.21 | 82.90 | 113.44 |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 2.50 |